# Johnson & Johnson (JNJ) — Q3-2024 Earnings Results

**Report date:** 2024-10-15 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2024

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.42 | N/A | +9.16% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's strategic direction. They noted the importance of innovation in driving future growth.

**Key quotes:**

> Management highlighted strong performance in key product lines.

> They emphasized ongoing investments in innovation and research.

> There was a focus on maintaining operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Johnson & Johnson's earnings report shows a solid EPS performance, indicating better-than-expected profitability. However, the lack of revenue data and guidance leaves some uncertainty about future growth. The stock reaction is not available, but the positive EPS surprise suggests that investors may view the results favorably.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2024_